newsfilter
← Latest News
Business Wire·

Gilead and Novo Nordisk Expand NASH Clinical Collaboration

FOSTER CITY, Calif. & BAGSVÆRD, Denmark--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Novo Nordisk A/S (Nasdaq Copenhagen: NOVO B) today announced that the companies have expanded their clinical collaboration in non-alcoholic steatohepatitis (NASH).